• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

FDA approves Botox for hyperhidrosis tx

Article

Irvine, Calif. - Sweat has a new enemy. Botox (botulinum toxin type A), developed by Allergan, has been approved by the U.S. Food and Drug Administration (FDA) to treat hyperhidrosis.

Related Videos
Related Content
FDA Issues Alert on Counterfeit Botox: What Dermatology Clinicians Need to Know

FDA Issues Alert on Counterfeit Botox: What Dermatology Clinicians Need to Know

Article
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

Podcast
New Data on Retinol: Patricia Farris, MD, Shares Insights on Anti-Aging

New Data on Retinol: Patricia Farris, MD, Shares Insights on Anti-Aging

Article
The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice

The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice

Podcast
Allergan Aesthetics Launches New Book to Bring More Awareness to Ethics in Aesthetics

Allergan Aesthetics Launches New Book to Bring More Awareness to Ethics in Aesthetics

Article
Habits, Cultural Norms, and Rapid Advances In Technology Have Dramatically Changed the Aesthetic Medicine Landscape

Habits, Cultural Norms, and Rapid Advances In Technology Have Dramatically Changed the Aesthetic Medicine Landscape

Article
© 2024 MJH Life Sciences

All rights reserved.